
United States · Hospital & health care startup
Andor Health is an AI-first healthcare technology company based in Orlando, Florida, founded in 2018 by Raj Toleti.
Funding reportedLast round: Series A
Andor Health is an AI-first healthcare technology company based in Orlando, Florida, founded in 2018 by Raj Toleti.
The company focuses on developing virtual health solutions that utilize generative artificial intelligence and voice technology to enhance clinical care delivery. Its mission is to improve communication and collaboration among care teams, optimize workflows, and ultimately drive better patient outcomes. The flagship product, ThinkAndor®, is a generative AI-powered virtual care platform that integrates with Electronic Medical Records (EMR) and Electronic Health Records (EHR). It provides real-time insights to clinicians, automates administrative tasks, and standardizes virtual health experiences. Additionally, Andor Health offers specialized modules, including AI agents for patient navigation, remote monitoring, and virtual consultations, catering to both healthcare systems and patients. The company is currently in the Series A funding stage and is recognized for its innovative approach in the HealthTech sector.
Funding, as reported
From Andor Health's own website: 8 on the team.
AdvisersNaveen Gupta
What they build
Known for
health carevirtual sittingai for remote specialty consultsvirtual care integrationhealthcareon demconsultsvirtual health platformvirtual triage aiai for hospital at homeai for reducing clinician burnoutvirtual rounding aiai for virtual waiting roomsai for virtual care scalabilityclinical workflow automationai healthcare platforminformation technology & services
Built with from their website
Microsoft Azure MonitorGoogle MapsAzure DevopsZendeskMicrosoft Entra IDMicrosoft Power BIKioskedCloudFlare CDNGoogle Tag ManagerNVIDIA Jetson
IBM MaaS360Priority HintsReactCAPTCHAGoogle Font APIJavaScriptBASEWordPress.org
Add your raise, your deck and your story, and put Andor Health in front of investors. Or tell us what we have wrong.